Global Macular Degeneration Treatment Market to Soar to USD 23.29 Billion by 2029, Reveals Latest Industry Analysis [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
Dublin, March 26, 2024 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029" report has been added to ResearchAndMarkets.com's offering. Growth Trajectory of the Macular Degeneration Treatment Market The latest industry report indicates that the global market for macular degeneration treatment is poised for substantial growth, with projections estimating the market will expand to USD 23.29 billion by the year 2029, progressing at a Compound Annual Growth Rate (CAGR) of 8.51% from 2024 to 2029. This growth is attributed to the rising prevalence of retinal disorders, an aging global population, and intensified research and development efforts in the field. Impact of COVID-19 and Subsequent Recovery on the Market The COVID-19 pandemic impacted various sectors, including macular degeneration treatment services. A noted downturn in clinic visits and treatments received highlighted the pandemic's
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies and Better Predict Human Outcomes for Age-Related Diseases [Yahoo! Finance]Yahoo! Finance
- 20 Countries with the Highest Rates of Stomach Cancer in the World [Yahoo! Finance]Yahoo! Finance
- Novartis AG (NYSE: NVS) had its price target raised by analysts at BMO Capital Markets from $114.00 to $116.00. They now have a "market perform" rating on the stock.MarketBeat
- Roche Sales Decline in Last Quarter of Pandemic Impact [BNN Bloomberg (Canada)]BNN Bloomberg
- Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 4/23/24 - Beat
NVS
Sec Filings
- 4/23/24 - Form 6-K
- 2/15/24 - Form S-8
- 2/2/24 - Form SC
- NVS's page on the SEC website